$2440.25—Stale · 2 weeks old
BSE • Last print 2 weeks ago
$2440.25—Stale · 2 weeks old
Glenmark Pharmaceuticals Ltd. is a prominent global pharmaceutical company engaged in the research, development, and manufacturing of a wide range of pharmaceutical products. Established in 1977 and headquartered in Mumbai, India, Glenmark has developed a robust portfolio that includes both generic and branded medications across multiple therapeutic areas, including respiratory, dermatology, and oncology. The company's research and development efforts are prominently focused on innovative biologics and new chemical entities, underscoring its commitment to addressing unmet medical needs. Through its R&D centers and manufacturing plants spread across several countries, Glenmark has established a significant presence in the domestic market while also catering to international markets, effectively contributing to the global healthcare industry. Glenmark Pharmaceuticals plays a crucial role in the pharmaceutical sector by striving to make healthcare affordable and accessible. Its capacity to supply high-quality pharmaceutical solutions at competitive prices enhances its market reputation, making it a vital player in addressing global health challenges through innovation and strategic partnerships.